Profound Medical Corp (PROF)

$7.35 -0.08 (-1.08%)
Market Cap 223.11M
Revenue (ttm) 7.20M
Net Income (ttm) -28.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -396.81%
Debt to Equity Ratio 0.18
Volume 57,600
Avg Vol 77,596
Day's Range N/A - N/A
Shares Out 30.03M
Stochastic %K 34%
Beta 0.85
Analysts Strong Sell
Price Target $15.67

Latest News on PROF

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

Jan 8, 2025, 7:30 AM EST - 10 days ago

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 8:15 AM EST - 12 days ago

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

Dec 10, 2024, 9:55 AM EST - 5 weeks ago

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

Dec 6, 2024, 9:04 AM EST - 6 weeks ago

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

Profound Medical Announces Proposed Public Offering of Common Shares

Dec 5, 2024, 4:48 PM EST - 6 weeks ago

Profound Medical Announces Proposed Public Offering of Common Shares

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

Dec 2, 2024, 7:30 AM EST - 6 weeks ago

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant'

Nov 26, 2024, 7:45 AM EST - 7 weeks ago

Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant'

Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript

Nov 10, 2024, 8:50 AM EST - 2 months ago

Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript

Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

Nov 4, 2024, 6:55 AM EST - 2 months ago

Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow

Oct 17, 2024, 4:30 PM EDT - 3 months ago

Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow

Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer

Oct 16, 2024, 4:15 PM EDT - 3 months ago

Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer

Profound Medical to Participate in Lake Street's Best Ideas Growth Conference

Sep 4, 2024, 4:30 PM EDT - 4 months ago

Profound Medical to Participate in Lake Street's Best Ideas Growth Conference

Profound Medical Corporation (PROF) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 11:11 PM EDT - 5 months ago

Profound Medical Corporation (PROF) Q2 2024 Earnings Call Transcript

Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

Jul 18, 2024, 4:30 PM EDT - 6 months ago

Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases

Jul 11, 2024, 7:00 AM EDT - 6 months ago

Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases

Profound Medical Annual General Meeting of Shareholders Voting Results

May 15, 2024, 5:00 PM EDT - 8 months ago

Profound Medical Annual General Meeting of Shareholders Voting Results

Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan

May 14, 2024, 7:30 AM EDT - 8 months ago

Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan

Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript

May 11, 2024, 1:47 PM EDT - 9 months ago

Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript

Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum

May 6, 2024, 4:15 PM EDT - 9 months ago

Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow

Apr 22, 2024, 4:15 PM EDT - 9 months ago

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow

Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Apr 9, 2024, 7:45 AM EDT - 10 months ago

Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 11:35 PM EST - 11 months ago

Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript

Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 7, 2024, 4:05 PM EST - 11 months ago

Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

Mar 4, 2024, 4:30 PM EST - 11 months ago

Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

Feb 27, 2024, 7:45 AM EST - 11 months ago

Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow

Feb 15, 2024, 4:30 PM EST - 1 year ago

Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow

Profound Medical Announces Non-Brokered Private Placement

Jan 16, 2024, 4:30 PM EST - 1 year ago

Profound Medical Announces Non-Brokered Private Placement

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

Jan 3, 2024, 4:15 PM EST - 1 year ago

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

Dec 27, 2023, 10:40 PM EST - 1 year ago

Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

Nov 8, 2023, 7:45 AM EST - 1 year ago

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript

Nov 4, 2023, 11:45 AM EDT - 1 year ago

Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript

Profound Medical Announces CMS Extension of Temporary ‘Code' for TULSA to ASC Setting

Nov 3, 2023, 8:00 AM EDT - 1 year ago

Profound Medical Announces CMS Extension of Temporary ‘Code' for TULSA to ASC Setting

Profound Medical Announces Third Quarter 2023 Financial Results

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Profound Medical Announces Third Quarter 2023 Financial Results

Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow

Oct 19, 2023, 4:30 PM EDT - 1 year ago

Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow

Profound Medical 2023 Virtual Analyst & Investor Day Agenda

Oct 10, 2023, 4:30 PM EDT - 1 year ago

Profound Medical 2023 Virtual Analyst & Investor Day Agenda

Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

Sep 25, 2023, 4:05 PM EDT - 1 year ago

Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

Sep 19, 2023, 4:45 PM EDT - 1 year ago

Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

Sep 6, 2023, 7:23 PM EDT - 1 year ago

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

Profound Medical Corp. (PROF) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 11:08 PM EDT - 1 year ago

Profound Medical Corp. (PROF) Q2 2023 Earnings Call Transcript

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow

Aug 2, 2023, 4:30 PM EDT - 1 year ago

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow

Profound Medical: TULSA-PRO Now Selling, Recurring Revenues Up 43%

Jun 22, 2023, 5:10 AM EDT - 1 year ago

Profound Medical: TULSA-PRO Now Selling, Recurring Revenues Up 43%

Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases

Jun 2, 2023, 1:40 PM EDT - 1 year ago

Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases

Profound Medical Announces Upcoming Investor Events

May 30, 2023, 8:00 AM EDT - 1 year ago

Profound Medical Announces Upcoming Investor Events

Profound Medical to Participate in A.G.P.'s Virtual Healthcare Conference

May 18, 2023, 8:00 AM EDT - 1 year ago

Profound Medical to Participate in A.G.P.'s Virtual Healthcare Conference

Profound Medical Annual and Special Meeting of Shareholders Voting Results

May 17, 2023, 4:15 PM EDT - 1 year ago

Profound Medical Annual and Special Meeting of Shareholders Voting Results

Profound Medical Corp. (PROF) Q1 2023 Earnings Call Transcript

May 10, 2023, 11:08 PM EDT - 1 year ago

Profound Medical Corp. (PROF) Q1 2023 Earnings Call Transcript

TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting

May 1, 2023, 4:30 PM EDT - 1 year ago

TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting

Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow

Apr 19, 2023, 4:30 PM EDT - 1 year ago

Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow

Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Apr 19, 2023, 4:15 PM EDT - 1 year ago

Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Profound Medical Corp. (PROF) Q4 2022 Earnings Call Transcript

Mar 7, 2023, 9:22 PM EST - 2 years ago

Profound Medical Corp. (PROF) Q4 2022 Earnings Call Transcript